Health: Diabetes News

Today is July 10, 2024. All times in Eastern Daylight Time.

Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs

07/09/2024 - 10:07 AM

BUSINESS WIRE
DocGo and Spect Partner to Reduce Care Gaps and Improve Eye and Vision Health

07/09/2024 - 07:35 AM

BUSINESS WIRE
Ophthalmic Devices Analysis Report 2024-2032: $10.22 Bn Market by Diagnostic & Monitoring Devices, Surgical Devices, Vision Correction Devices, Application, End User, Regions and Company Landscape - ResearchAndMarkets.com

07/08/2024 - 10:50 AM

BUSINESS WIRE
Xeris Biopharma Announces CEO Succession Plan

07/08/2024 - 07:00 AM

BUSINESS WIRE
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024

07/08/2024 - 06:00 AM

BUSINESS WIRE
Walgreens Strengthens Support for Children and Adults Living with Diabetes

07/02/2024 - 11:26 AM

BUSINESS WIRE
Xevant and Ivím Health Join Forces to Bring First Full Service Corporate GLP-1 Program, Ivím at Work, to Employees

07/01/2024 - 07:00 AM

BUSINESS WIRE
First Test Facilities and Products Recognized Under New IEEE Cybersecurity Certification Program for Medical Devices

06/27/2024 - 09:00 AM

BUSINESS WIRE
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.

06/27/2024 - 08:30 AM

BUSINESS WIRE
Dr. Prem Reddy Family Foundation Awards Scholarships to 88 Students Pursuing Careers in Healthcare

06/26/2024 - 04:36 PM

BUSINESS WIRE
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business

06/26/2024 - 11:26 AM

BUSINESS WIRE
Pleural Dynamics Treats First Patient in “The ACES Study for Aseptic Pleural Effusions,” a Post Market Clinical Study for its Novel ACES™ Automatic Continuous Effusion Shunt System

06/26/2024 - 10:00 AM

BUSINESS WIRE
Xeno Biosciences Starts Phase 1b Proof-of-Concept Study in Obesity

06/25/2024 - 04:34 PM

BUSINESS WIRE
Arrowhead Pharmaceuticals to Advance RNAi-based Plozasiran into Phase 3 CAPITAN Cardiovascular Outcomes Trial

06/25/2024 - 01:55 PM

BUSINESS WIRE
Welldoc Announces Collaboration to Support Cardiometabolic Health by Integrating AI-Driven Digital Coaching with Instacart’s Innovative Technology Platform to Increase Access to Nutritious Groceries

06/25/2024 - 10:00 AM

BUSINESS WIRE
Spectacular Labs Joins Forces with Canadian Centre for Meat Innovation & Technology to Improve Food Safety Testing

06/25/2024 - 08:03 AM

BUSINESS WIRE
Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020

06/25/2024 - 08:00 AM

BUSINESS WIRE
City of Hope Diabetes Experts Presented Innovative Research at Annual American Diabetes Association (ADA) Conference

06/24/2024 - 02:23 PM

BUSINESS WIRE
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States

06/24/2024 - 09:50 AM

BUSINESS WIRE
Patients Most In Need Face Obstacles to Participating in Life-Saving Clinical Trials According to a New Milken Institute Report

06/24/2024 - 09:30 AM

BUSINESS WIRE
Klick Health Brings Home 8 Cannes Lions, Moves up to #3 Overall Independent Agency While Maintaining #2 Healthcare Agency and #2 Healthcare Network Agency of the Year Rankings

06/24/2024 - 09:17 AM

BUSINESS WIRE
Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE

06/24/2024 - 07:30 AM

BUSINESS WIRE
Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal

06/24/2024 - 07:00 AM

BUSINESS WIRE
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver

06/24/2024 - 07:00 AM

BUSINESS WIRE
HighField Biopharmaceuticals’ mRNA-based HFG1 Demonstrates Potential as a Longer Acting GLP-1R Agonist for Diabetic Control and Weight Loss

06/24/2024 - 05:30 AM

BUSINESS WIRE

1 2 3

Next »

Search